MarketWatch: Brazilian Tuberculosis Research Network to Evaluate PharmaJet(R) Needle-free Tropis(R) ID Injection Device as Delivery System for Tuberculin Skin Test Brazilian Tuberculosis Research Network to Evaluate PharmaJet(R) Needle-free Tropis(R) ID Injection Device as Delivery System for Tuberculin Skin Test A new skin test for tuberculosis infection has proven safe, easy to administer and accurate in two Phase III clinical trials, according to research presented at the ATS 2016 International Conference. Q I got a tuberculosis skin test for my health care job and tested positive. A follow-up blood test was also positive, and I was diagnosed with latent TB.

Understanding the Context

However, ... Yahoo Finance: Brazilian Tuberculosis Research Network to Evaluate PharmaJet® Needle-free Tropis® ID Injection Device as Delivery System for Tuberculin Skin Test Brazilian Tuberculosis Research Network to Evaluate PharmaJet® Needle-free Tropis® ID Injection Device as Delivery System for Tuberculin Skin Test While tuberculosis spread is not significant nationally, lack of awareness of the latent form of the condition raises legitimate concerns for potential future infections. PharmaJet (R) , a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...